In this video, Motley Fool health-care analyst David Williamson discusses what investors should look for in Eli Lilly's upcoming earnings report, and what the big pharma has in store for 2013.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.